A Clinical Study to Assess the Safety, Tolerability of JNJ-63733657 and to evaluate how fast and to what extent JNJ-63733657 reaches the bloodstream and is absorbed, modified and removed from the body when administered as a Subcutaneous Infusion Using a Syringe Pump and as an Intravenous Infusion in Healthy Adult Participants
This research study, called JNJ-63733657, aims to understand a new potential medicine. We are looking for healthy adult volunteers to help us learn more. The main goals are to check if the medicine is safe and if people can take it without too many side effects (this is called 'tolerability'). We also want to find out how quickly the medicine gets into the bloodstream and how the body uses and gets rid of it. Participants will receive the medicine in two different ways: either by a small pump giving it just under the skin (subcutaneous infusion) or directly into a vein (intravenous infusion). This is an early-stage study, meaning it's one of the first times this medicine is being tested in humans.
At a glance
What is this study about?
This study is about a new medicine called JNJ-63733657. Even though the medicine might eventually be used for conditions like Alzheimer's Disease, this particular study is being done on healthy adults, not people with a specific illness. This is a common and important first step in testing new medicines.
The main aim of this study is to learn about how the medicine works in the body and to make sure it's safe. We call this 'human pharmacology.' Researchers want to find out how quickly and how much of the medicine gets into your blood, how your body changes it, and how it eventually leaves your system. This helps them understand the best way to give the medicine and what dose might be most effective and safest in the future.
Participants will receive the medicine in two different ways. One way is through a device called a syringe pump, which delivers the medicine slowly and steadily just under the skin. The other way is directly into a vein, similar to when you have an IV drip. By testingboth methods, researchers can see which way might be better for future patients.
Key takeaways
- This study tests a new medicine (JNJ-63733657) in healthy adults.
- It aims to check safety, tolerability, and how the medicine moves through the body.
- The medicine will be given in two ways: under the skin and into a vein.
- This is an important early step in developing new treatments.
- Your participation is valuable for future medical advancements.
Who may be eligible?
To take part in this study, you need to be a healthy adult. This means you should be 18 years old or older, and there's no upper age limit. Both men and women are welcome to participate.
Being 'healthy' means you shouldn't have any major ongoing medical conditions that could interfere with the study or make taking the medicine unsafe for you. The study team will do some checks to make sure you fit this description.
It's important to remember that this study is not for people who currently have Alzheimer's Disease or any other illness. It's specifically for healthy volunteers.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Do you consider yourself to be in good general health?
- Do you not have any major ongoing medical conditions or illnesses?
- Are you able to attend several study visits as required?
What does participation involve?
If you decide to take part, you'll need to attend several visits at the study clinic. During these visits, you will have various health checks, such as blood tests, heart checks (ECGs), and other examinations to ensure you are healthy enough to participate.
You will receive the study medicine, JNJ-63733657, in two different ways: through a small pump under your skin and through an IV drip into a vein. The medical staff will carefully monitor you during and after you receive the medicine. There will also be follow-up appointments after you've received the medicine to check on your well-being. The total length of your participation, including all visits and follow-ups, will be explained in detail by the study team.
Potential risks and benefits
Locations (1)
- —UnverifiedBelgium
Common questions
Why is this study being done on healthy people if the medicine might be for Alzheimer's?
Testing new medicines in healthy people first helps us understand how the medicine behaves in the body and if it's safe before giving it to people who are unwell.
What does 'subcutaneous infusion' mean?
This is when the medicine is given slowly and steadily just under your skin, often using a small pump, rather than directly into a vein.
Will I know if I'm getting the actual medicine or a placebo?
In this specific study, participants will receive the active medicine. There might be different doses or ways of giving it, but everyone will receive the study drug.
How long will I need to be in the study?
The total duration of your participation, including all visits and follow-ups, will be clearly explained by the study team. It can vary depending on the study's design.
Will I get paid for taking part?
Many early-stage studies in healthy volunteers offer some compensation for time, travel, and inconvenience. You should ask the study team about this.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.